Acadia Pharmaceuticals reported $16K in Ordinary Share Capital for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Acadia Pharmaceuticals ACAD:US $ 0.02M 0M
ALKERMES ALKS:US $ 1.68M 0.02M
Alnylam Pharmaceuticals ALNY:US $ 1.21M 0M
Aptinyx Inc APTX:US $ 677K 0
Biogen BIIB:US $ 0.1M 0M
Biomarin Pharmaceutical BMRN:US $ 0.18M 0M
Bristol Myers Squibb BMY:US $ 292M 0M
Cara Therapeutics CARA:US $ 53K 0
Corcept Therapeutics CORT:US $ 0.13M 0M
Cytokinetics CYTK:US $ 0.08M 0M
Eisai 4523:JP Y 44986M 0M
Eli Lilly And LLY:US $ 594.1M 2.2M
Intercept Pharmaceuticals ICPT:US $ 0.03M 0M
Intra Cellular Therapies ITCI:US $ 0.01M 0M
Johnson & Johnson JNJ:US $ 3120M 0M
Marinus Pharmaceuticals MRNS:US $ 0.04M 0M
Moderna Inc MRNA:US 40K 40K
Prothena PRTA:US $ 0.47M 0M
Ptc Therapeutics PTCT:US $ 0.07M 0M
Sarepta Therapeutics SRPT:US $ 0.01M 0M
Seattle Genetics SGEN:US $ 0.18M 0M
Ultragenyx Pharmaceutical RARE:US $ 0.07M 0M
Vanda Pharmaceuticals VNDA:US $ 0.06M 0M
Vertex Pharmaceuticals VRTX:US $ 2.6M 0.1M
YTE INCY:US $ 0.22M 0M